MELINTA THERAPETUICS, INC. and , as Trustee INDENTURE DATED AS OFMelinta Therapeutics, Inc. /New/ • January 26th, 2018 • Pharmaceutical preparations • New York
INDENTURE, dated as of [ ] between Melinta Therapeutics, Inc. (the “Company”), a Delaware corporation having its principal office at 300 George Street, Suite 301, New Haven, Connecticut 06511 and [ ] (the “Trustee”). Each party agrees as follows for the benefit of each other party and for the equal and ratable benefit of the Holders of the Company’s debentures, notes or other evidences of unsecured indebtedness to be issued in one or more series (“Securities”):
